Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09XJF
|
|||
| Drug Name |
EPI 589
|
|||
| Synonyms |
(R)-troloxamide quinone; EPI-589
Click to Show/Hide
|
|||
| Indication | Amyotrophic lateral sclerosis [ICD-11: 8B60.0] | Phase 2 | [1] | |
| Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 2 | [1] | ||
| Company |
BioElectron Technology Mountain View, CA Sumitomo Dainippon Pharma Osaka, Japan
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Quinone reductase (NQO) | Target Info | Modulator | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.